ArticleAmerican journal of cancer research2019

Metformin reverses PARP inhibitors-induced epithelial-mesenchymal transition and PD-L1 upregulation in triple-negative breast cancer.

Ye Han et al.PubMed ↗Full text ↗

No numbers read from the abstract.